334
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma

, , , , , , , , , , ORCID Icon, , & ORCID Icon show all
Pages 144-155 | Received 05 Nov 2018, Accepted 04 Feb 2019, Published online: 25 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qin Xia, Liqun Liu, Yang Li, Pei Zhang, Da Han & Lei Dong. (2021) Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment. Cancer Investigation 39:8, pages 627-644.
Read now

Articles from other publishers (15)

Emir Begagić, Ragib Pugonja, Hakija Bečulić, Amila Čeliković, Lejla Tandir Lihić, Samra Kadić Vukas, Lejla Čejvan, Rasim Skomorac, Edin Selimović, Belma Jaganjac, Fatima Juković-Bihorac, Aldin Jusić & Mirza Pojskić. (2023) Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings. Brain Sciences 13:11, pages 1602.
Crossref
Luke R. Odell, Nigel C. Jones, Ngoc Chau, Mark J. Robertson, Joseph I. Ambrus, Fiona M. Deane, Kelly A. Young, Ainslie Whiting, Jing Xue, Kate Prichard, James A. Daniel, Nick N. Gorgani, Terence J. O'Brien, Phillip J. Robinson & Adam McCluskey. (2023) The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models. RSC Medicinal Chemistry 14:8, pages 1492-1511.
Crossref
Logan Muzyka, Nicolas K. Goff, Nikita Choudhary & Michael T. Koltz. (2023) Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies. International Journal of Molecular Sciences 24:13, pages 10456.
Crossref
Luke R. Odell, Mark J Robertson, Kelly A Young, Andrew B. McGeachie, Annie Quan, Phillip J. Robinson & Adam McCluskey. (2022) Prodrugs of the Archetypal Dynamin Inhibitor Bis‐T‐22. ChemMedChem 17:24.
Crossref
Sadegh Safaei, Roya Sajed, Leili Saeednejad Zanjani, Mandana Rahimi, Fahimeh Fattahi, Golnaz Ensieh Kazemi-Sefat, Mahdieh Razmi, Shima Dorafshan, Leila Eini, Zahra Madjd & Roya Ghods. (2022) Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma. Cancer Biomarkers 35:1, pages 27-45.
Crossref
Chieh-Fan Yin, Yi-Wen Chang, Hsuan-Cheng Huang & Hsueh-Fen Juan. (2022) Targeting protein interaction networks in mitochondrial dynamics for cancer therapy. Drug Discovery Today 27:4, pages 1077-1087.
Crossref
Cecilia C. Russell, Kate L. Prichard, Nicholas S. O’Brien, Adam McCluskey, Phillip J. Robinson & Jennifer R. Baker. 2022. Synaptic Vesicles. Synaptic Vesicles 239 258 .
Delphine Trochet & Marc Bitoun. (2021) A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Cedric S. Tremblay, Stephen B. Ting, Adam McCluskey, Phillip J. Robinson & David J. Curtis. (2021) Shutting the gate: targeting endocytosis in acute leukemia. Experimental Hematology 104, pages 17-31.
Crossref
Mohammad Jalili-Nik, Farzaneh Abbasinezhad-moud, Sajad Sahab-Negah, Abolfazl Maghrouni, Mohammad Etezad Razavi, Maryam Khaleghi Ghadiri, Walter Stummer & Ali Gorji. (2021) Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells. International Journal of Molecular Sciences 22:11, pages 5596.
Crossref
Eilam Yeini, Paula Ofek, Nitzan Albeck, Daniel Rodriguez Ajamil, Lena Neufeld, Anat Eldar‐Boock, Ron Kleiner, Daniella Vaskovich, Shani Koshrovski‐Michael, Sahar Israeli Dangoor, Adva Krivitsky, Christian Burgos Luna, Gal Shenbach‐Koltin, Miki Goldenfeld, Ori Hadad, Galia Tiram & Ronit Satchi‐Fainaro. (2020) Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Advanced Therapeutics 4:1, pages 2000124.
Crossref
Cedric S. Tremblay, Sung Kai Chiu, Jesslyn Saw, Hannah McCalmont, Veronique Litalien, Jacqueline Boyle, Stefan E. Sonderegger, Ngoc Chau, Kathryn Evans, Loretta Cerruti, Jessica M. Salmon, Adam McCluskey, Richard B. Lock, Phillip J. Robinson, Stephen M. Jane & David J. Curtis. (2020) Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells. Nature Communications 11:1.
Crossref
Hao Cheng, Xiaofei Cao, Xinxu Min, Xiaojin Zhang, Qiuyue Kong, Qian Mao, Rongrong Li, Bin Xue, Lei Fang, Li Liu & Zhengnian Ding. (2020) Heat‐Shock protein A12A is a novel PCNA‐binding protein and promotes hepatocellular carcinoma growth. The FEBS Journal 287:24, pages 5464-5477.
Crossref
Jubo Wang, Yu Quan, Jian Lv, Shouping Gong & Danfeng Dong. (2019) BRD4 promotes glioma cell stemness via enhancing miR‐142‐5p‐mediated activation of Wnt/β‐catenin signaling. Environmental Toxicology 35:3, pages 368-376.
Crossref
Thomas Daubon, Joris Guyon, Anne-Aurélie Raymond, Benjamin Dartigues, Justine Rudewicz, Zakaria Ezzoukhry, Jean-William Dupuy, John M J Herbert, Frédéric Saltel, Rolf Bjerkvig, Macha Nikolski & Andreas Bikfalvi. (2019) The invasive proteome of glioblastoma revealed by laser-capture microdissection. Neuro-Oncology Advances 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.